These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1205 related articles for article (PubMed ID: 9257254)

  • 21. Comparison of cyclosporine and tacrolimus in combination with rabbit antithymocyte immunoglobulins as induction therapy in cardiac transplantation.
    Jacques F; Carrier M; Pelletier GB; Racine N; White M; Perrault LP; Pellerin M
    Transplant Proc; 2009 Oct; 41(8):3337-41. PubMed ID: 19857745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of Quilty lesion in cardiac allografts: relationship to reduced endocardial cyclosporine A.
    Freimark D; Czer LS; Aleksic I; Ruan XM; Admon D; Blanche C; Trento A; Fishbein MC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1197-203. PubMed ID: 8719467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of surveillance biopsies in infant heart transplant recipients.
    Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction with and without antithymocyte globulin combined with cyclosporine/tacrolimus-based immunosuppression in renal transplantation: a meta-analysis of randomized controlled trials.
    Tian JH; Wang X; Yang KH; Liu AP; Luo XF; Zhang J
    Transplant Proc; 2009 Nov; 41(9):3671-6. PubMed ID: 19917365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial.
    Baran DA; Zucker MJ; Arroyo LH; Camacho M; Goldschmidt ME; Nicholls SJ; Prevost-Fernandez J; Carr C; Adams L; Pardi S; Hou V; Binetti M; McCahill J; Chichetti J; Viloria V; Sanagustin MG; Ebuenga-Smith J; Mele L; Martin A; Blicharz D; Wolski K; Olesnicky L; Qian F; Gass AL; Cohen M
    Circ Heart Fail; 2011 Mar; 4(2):129-37. PubMed ID: 21216835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between endomyocardial biopsy score and cyclosporine 2-h post-dose levels (C) in heart transplant patients receiving anti-thymocyte globulin induction.
    Cantarovich M; Giannetti N; Cecere R
    Clin Transplant; 2004 Apr; 18(2):148-51. PubMed ID: 15016128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T;
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine.
    Castel MA; Farrero M; Vallejos I; Cardona M; Regueiro A; Pérez-Villa F
    Transplant Proc; 2011; 43(6):2244-6. PubMed ID: 21839245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
    van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
    J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation.
    Czer LS; Phan A; Ruzza A; Rafiei M; Setareh-Shenas S; Caceres M; Awad M; Soliman C; Mirocha J; De Robertis M; Kass RM; Trento A
    Transplant Proc; 2013; 45(6):2393-8. PubMed ID: 23953554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
    Onsager DR; Canver CC; Jahania MS; Welter D; Michalski M; Hoffman AM; Mentzer RM; Love RB
    J Heart Lung Transplant; 1999 May; 18(5):448-55. PubMed ID: 10363689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus monotherapy in adult cardiac transplant recipients: intermediate-term results.
    Baran DA; Segura L; Kushwaha S; Courtney M; Correa R; Fallon JT; Cheng J; Lansman SL; Gass AL
    J Heart Lung Transplant; 2001 Jan; 20(1):59-70. PubMed ID: 11166613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of cyclosporine A to tacrolimus following heart transplantation.
    Mathieu P; Carrier M; White M; Pellerin M; Perrault LP; Pelletier G; Pelletier LC
    Can J Cardiol; 1999 Nov; 15(11):1229-32. PubMed ID: 10579737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL
    Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM
    Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
    Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
    Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation.
    Horning NR; Lynch JP; Sundaresan SR; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Aug; 17(8):761-7. PubMed ID: 9730424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of antilymphocyte induction therapy in liver transplantation.
    Wall WJ
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
    Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
    Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European Multicenter Tacrolimus (FK506) Heart Pilot Study: one-year results--European Tacrolimus Multicenter Heart Study Group.
    Reichart B; Meiser B; Viganò M; Rinaldi M; Martinelli L; Yacoub M; Banner NR; Gandjbakhch I; Dorent R; Hetzer R; Hummel M
    J Heart Lung Transplant; 1998 Aug; 17(8):775-81. PubMed ID: 9730426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.